Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goossens

Showing results (81-90 of 456) with videos related to

Pageof 46
Sort By:
Acta Clinica Belgica|March 26, 2009
Cefepime and amikacin as empirical therapy in patients with febrile neutropaenia: a single-centre phase II prospective surveyJ Mebis, S Vandeplassche, H Goossens, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 5, 2001
['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system]H Goossens, W Peetermans, J P Sion, et al.
Annals of the Rheumatic Diseases|May 15, 2001
Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapyP H Goossens, R J Verburg, F C Breedveld
Frontiers in Nutrition|January 25, 2021
The Impact of Artificial Sweeteners on Body Weight Control and Glucose HomeostasisMichelle D Pang, Gijs H Goossens, Ellen E Blaak
Lancet (London, England)|April 8, 1989
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDSS De Wit, D Weerts, H Goossens, et al.
International Journal of Systematic Bacteriology|November 11, 1999
Identification of clinically relevant viridans streptococci by analysis of transfer DNA intergenic spacer length polymorphismY De Gheldre, P Vandamme, H Goossens, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-makingJ Acar, M Casewell, J Freeman, et al.
Deutsche Medizinische Wochenschrift (1946)|December 7, 1984
[Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy]G Becker, H Goossens, K Seemann, et al.
Sexually Transmitted Infections|February 11, 2003
First, do not harm: also an issue in NAA assay diagnostics for chlamydial infectionV Verhoeven, M Ieven, A Meheus, et al.
Molecular and Cellular Probes|September 4, 1998
Construction of an internal control for the detection of Chlamydia pneumoniae by PCRD Ursi, M Ieven, H P Van Bever, et al.
Pageof 46

Showing results (81-90 of 456) with videos related to

Sort By:
Pageof 46
Acta Clinica Belgica|March 26, 2009
Cefepime and amikacin as empirical therapy in patients with febrile neutropaenia: a single-centre phase II prospective surveyJ Mebis, S Vandeplassche, H Goossens, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 5, 2001
['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system]H Goossens, W Peetermans, J P Sion, et al.
Annals of the Rheumatic Diseases|May 15, 2001
Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapyP H Goossens, R J Verburg, F C Breedveld
Frontiers in Nutrition|January 25, 2021
The Impact of Artificial Sweeteners on Body Weight Control and Glucose HomeostasisMichelle D Pang, Gijs H Goossens, Ellen E Blaak
Lancet (London, England)|April 8, 1989
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDSS De Wit, D Weerts, H Goossens, et al.
International Journal of Systematic Bacteriology|November 11, 1999
Identification of clinically relevant viridans streptococci by analysis of transfer DNA intergenic spacer length polymorphismY De Gheldre, P Vandamme, H Goossens, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-makingJ Acar, M Casewell, J Freeman, et al.
Deutsche Medizinische Wochenschrift (1946)|December 7, 1984
[Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy]G Becker, H Goossens, K Seemann, et al.
Sexually Transmitted Infections|February 11, 2003
First, do not harm: also an issue in NAA assay diagnostics for chlamydial infectionV Verhoeven, M Ieven, A Meheus, et al.
Molecular and Cellular Probes|September 4, 1998
Construction of an internal control for the detection of Chlamydia pneumoniae by PCRD Ursi, M Ieven, H P Van Bever, et al.
Pageof 46